Leading Providers of RUSH Immunotherapy, Sublingual Immunotherapy and Bioidentical Hormone Treatment Sign Exclusive Agreement for Vietnamese Treatment Facility Expansion
Posted on: Tuesday, 22 November 2005, 09:00 CST
AUSTIN, Texas, Nov. 22 /PRNewswire/ -- The Roby Institute and Schaupp Pte. Ltd (a health care provider domiciled in Vietnam) announced to internet marketing and PR firm Global VIP Traffic an agreement authorizing the exclusive licensing and use of The Roby Institute Allergy and RUSH Immunology therapies today.
Headquartered in Austin, TX, with treatment facilities in San Antonio, Marble Falls and Austin, The Roby Institute is a worldwide leader in RUSH Immunotherapy, SLIT, Neutralization and Bioidentical Hormone Treatment therapies. These noninvasive therapies offer immediate and significant relief for a wide range of chronic conditions, such as, migraine, pain, allergy, Asthma, Rheumatoid Arthritis, Chronic Fatigue (CFS), Fibromyalgia Syndrome (FMS), Weight Loss & Control, Menopause and Andropause related symptoms. Bioidentical Hormone Treatment has become more widely popular due to the release and promotion of Suzanne Somers' new book, The Sexy Years, in which she describes how Bioidentical Hormone Treatment relieved her menopausal symptoms.
Capitalizing on the successful performance of Dr. Roby's Sublingual Immunotherapy, Bioidentical Hormone Treatment and RUSH Immunotherapy, Schaupp Pte. Ltd, intends to open 10 treatment facilities throughout Vietnam. Dr. Dat Vu, Director of Clinic operations, commented, "We reviewed and selected The Roby Institute modalities in light of their almost instant [RUSH Immunotherapy] positive results, ease of training and use, and broad spectrum of conditions that can be treated."
The agreement also paves the way for H5n1 (bird flu) treatments and to be researched and developed in Vietnam. Recent news about this potential pandemic and the lack of available treatment options further increase the importance of this cooperative effort by the two companies.
The Roby Institute would not release further specific expansion plans at this time. Agreements are, however, expected over the course of the next two quarters in the European Union, South America, Eastern Europe and Asia.
About The Roby Institute
Dr. Russell Roby founded the Texan Allergy Center in Austin, Texas to assist residents of the Greater Austin area in combating allergy symptoms like nasal congestion, eye redness and soreness, sneezing, wheezing, coughing, pain, rashes/irritation, attention deficit disorder, and loss of short term memory. Dr. Roby is a world leader in Sublingual Immunotherapy, RUSH Immunotherapy and Bioidentical Hormone Treatment.
In 1995, http://www.onlineallergycenter.com/ was launched to provide allergy sufferers with helpful information and tips online.
The Roby Institute
CONTACT: Sandra Pickard, General Manager of The Roby Institute,+1-512-338-4336, sandra@drroby.com
Web site: http://www.onlineallergycenter.com/
Web site: http://www.drroby.com/
Source: PRNewswire
Related Articles
- Sublingual Immunotherapy For Inhalant Allergies Needs Deeper Consideration
- AstraZeneca's Drug Will Become the New Clinical Gold Standard by 2012 for the Treatment of Metastatic Hormone-Refractory Prostate Cancer
- Oral Immunotherapy Eases Milk Allergies In Trials
- A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms
- ProCure Treatment Centers Selects International Vendor to Equip Proton Therapy Center in Oklahoma
- Cobalis' EU Patent for PreHistin(R) Becomes Effective; Patent Protects Method of Treatment for Cobalis' PreHistin Anti-Allergy Medication
- Scottsdale Treatment Institute to Offer Hythiam's PROMETA(TM)
- Nearly 70% of Patients Who Take a First-Line Therapy for the Treatment of Schizophrenia Will Progress to a Second-Line Therapy Within 360 Days After Diagnosis
- MicroIslet and The Scripps Research Institute Extend Collaboration in Islet Cell Transplantation Therapies for Treatment of Insulin Dependent Diabetes
 |
 |
User Comments (0)
RSS Feeds